Biomarkers for AKI improve clinical practice: no

Intensive Care Medicine

Volumn 41, Issue 4, 2015, Pages 618-622

  Ostermann, Marlies ^a   Joannidis, Michael ^b  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; BIOLOGICAL MARKER; LCN2 PROTEIN, HUMAN; LIPOCALIN; ONCOPROTEIN;

ACUTE KIDNEY INJURY; BLOOD; EARLY DIAGNOSIS; GLOMERULUS FILTRATION RATE; HUMAN; PREDICTIVE VALUE; RISK FACTOR; URINE;

ACUTE KIDNEY INJURY; ACUTE-PHASE PROTEINS; BIOMARKERS; EARLY DIAGNOSIS; GLOMERULAR FILTRATION RATE; HUMANS; LIPOCALINS; PREDICTIVE VALUE OF TESTS; PROTO-ONCOGENE PROTEINS; RISK FACTORS;

EID: 84939976922     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-014-3540-0     Document Type: Editorial

References (20)

1. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group (2012) KDIGO clinical practice guideline for acute kidney injury. Kidney Int 2:1–138
2. Haase M, Bellomo R, Devarajan P, Schlattmann P, Haase-Fielitz A, NGAL Meta-analysis Investigator Group (2009) Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis 54:1012–1024
3. Wagener G, Gubitosa G, Wang S, Borregaard N, Kim M, Lee HT (2008) Urinary neutrophil gelatinase-associated lipocalin and acute kidney injury after cardiac surgery. Am J Kidney Dis 52(3):425–433
4. Martensson J, Bell M, Oldner A, Xu S, Venge P, Martling CR (2010) Neutrophil gelatinase-associated lipocalin in adult septic patients with and without acute kidney injury. Intensive Care Med 36:1333–1340
5. Haase M, Bellomo R, Devarajan P, Ma Q, Bennett MR, Möckel M, Matalanis G, Dragun D, Haase-Fielitz A (2009) Novel biomarkers early predict the severity of acute kidney injury after cardiac surgery in adults. Ann Thorac Surg 88:124–130
6. Ristikankare A, Poyhia R, Kuitunen A, Skrifvars M, Hämmäinen P, Salmenperä M, Suojaranta-Ylinen R (2010) Serum cystatin C in elderly cardiac surgery patients. Ann Thorac Surg 89:689–694
7. Soto K, Coelho S, Rodriques B, Martins H, Frade F, Lopes S, Cunha L, Papoila AL, Devarajan P (2010) Cystatin C as a marker of acute kidney injury in the emergency department. Clin J Am Soc Nephrol 5(10):1745–1754
8. Perianayagam MC, Seabra VF, Tighiouart H, Liangos O, Jaber BL (2009) Serum cystatin C for prediction of dialysis requirement or death in acute kidney injury: a comparative study. Am J Kidney Dis 54:1025–1033
9. Nejat M, Pickering JW, Walker RJ, Westhuyzen J, Shaw GM, Frampton CM, Endre ZH (2010) Urinary cystatin C is diagnostic of acute kidney injury and sepsis, and predicts mortality in the intensive care unit. Crit Care 14(3):R85
10. Tu Y, Wang H, Suni R, Ni Y, Ma L, Xv F, Hu X, Jiang L, Wu A (2014) Urinary netrin-1 and KIM-1 as early biomarkers for septic acute kidney injury. Ren Fail 26:1–5
11. Parikh CR, Thiessen-Philbrook H, Garg AX, Kadiyala D, Shlipak MG, Koyner JL, Edelstein CL, Devarajan P, Patel UD, Zappitelli M, Krawczeski CD, Passik CS, Coca SG, TRIBE-AKI Consortium (2013) Performance of kidney injury molecule-1 and liver fatty acid-binding protein and combined biomarkers of AKI after cardiac surgery. Clin J Am Soc Nephrol 8(7):1079–1088
12. Parr SK, Clark AJ, Bian A, Shintani AK, Wickersham NE, Ware LB, Ikizler TA, Siew ED (2014) Urinary L-FABP predicts poor outcomes in critically ill patients with early acute kidney injury. Kidney Int. doi:10.1038/ki.2014.301
13. Arthur JM, Hill EG, Alge JL, Lewis EC, Neely BA, Janech MG, Tumlin JA, Chawla LS, Shaw AD, SAKInet Investigators (2014) Evaluation of 32 urine biomarkers to predict the progression of acute kidney injury after cardiac surgery. Kidney Int 85(2):431–438
14. Kashani K, Al-Khafaji A, Ardiles T et al (2013) Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care 17:R25
15. Hoste EA, McCullough PA, Kashani K, Chawla LS, Joannidis M, Shaw AD, Feldkamp T, Uettwiller-Geiger DL, McCarthy P, Shi J, Walker MG, Kellum JA; for the Sapphire Investigators (2014) Derivation and validation of cutoffs for clinical use of cell cycle arrest biomarkers. Nephrol Dial Transplant. pii:gfu292 (Epub ahead of print. PubMed PMID: 25237065)
16. Bihorac A, Chawla LS, Shaw AD et al (2014) Validation of cell-cycle arrest biomarkers for acute kidney injury using clinical adjudication. Am J Respir Crit Care Med 189:932–939
17. Glassford NJ, Schneider AG, Xu S et al (2013) The nature and discriminatory value of urinary neutrophil gelatinase-associated lipocalin in critically ill patients at risk of acute kidney injury. Intensive Care Med 39:1714–1724
18. Legrand M, Darmon M, Joannidis M (2013) NGAL and AKI: the end of a myth? Intensive Care Med 39(10):1861–1863
19. Joannidis M, Forni LG (2011) Clinical review: timing of renal replacement therapy. Crit Care 15(3):223
20. Endre Z, Walker R, Pickering J et al (2010) Early intervention with erythropoietin does not affect the outcome of acute kidney injury (the EARLYARF trial). Kidney Int 77:1020–1030